InsidersTradesSigma
Follow the 贝瑞基因 share price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 贝瑞基因 has logged 5 public disclosures. Market capitalisation: €3.1bn. The latest transaction was disclosed on 11 May 2026 (Sale). Among the most active insiders: 高扬. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
贝瑞基因 es una empresa especializada en el sector de la salud y farmacéutico, que ofrece servicios genómicos y de diagnóstico. Cotiza en el mercado XSHE.